Skip to main content
Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas

Fig. 2

Receiver operating characteristic curves for serum levels of CA19-9, CA125 and CEA. Receiver operating characteristic curves of CA19-9 (A), CA125 (B) and CEA (C) for predicting malignant IPMNs. AUC, area under curve; CA19-9, carbohydrate antigen 19-9; CA125, carbohydrate antigen 125; CEA, carcinoembryonic antigen; IPMN, intraductal papillary mucinous neoplasm

Back to article page